Cargando…
MYC-family protein overexpression and prominent nucleolar formation represent prognostic indicators and potential therapeutic targets for aggressive high-MKI neuroblastomas: a report from the children’s oncology group
Neuroblastomas with a high mitosis-karyorrhexis index (High-MKI) are often associated with MYCN amplification, MYCN protein overexpression and adverse clinical outcome. However, the prognostic effect of MYC-family protein expression on these neuroblastomas is less understood, especially when MYCN is...
Autores principales: | Niemas-Teshiba, Risa, Matsuno, Ryosuke, Wang, Larry L., Tang, Xao X., Chiu, Bill, Zeki, Jasmine, Coburn, Jeannine, Ornell, Kimberly, Naranjo, Arlene, Van Ryn, Collin, London, Wendy B., Hogarty, Michael D., Gastier-Foster, Julie M., Look, A. Thomas, Park, Julie R., Maris, John M., Cohn, Susan L., Seeger, Robert C., Asgharzadeh, Shahab, Ikegaki, Naohiko, Shimada, Hiroyuki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5814222/ https://www.ncbi.nlm.nih.gov/pubmed/29464082 http://dx.doi.org/10.18632/oncotarget.23740 |
Ejemplares similares
-
Augmented expression of MYC and/or MYCN protein defines highly aggressive MYC-driven neuroblastoma: a Children's Oncology Group study
por: Wang, L L, et al.
Publicado: (2015) -
Local delivery of dinutuximab from lyophilized silk fibroin foams for treatment of an orthotopic neuroblastoma model
por: Ornell, Kimberly J., et al.
Publicado: (2020) -
Clinical Relevance of CD4 Cytotoxic T Cells in High-Risk Neuroblastoma
por: Tang, Xao X., et al.
Publicado: (2021) -
Macrophage-mediated anti-tumor immunity against high-risk neuroblastoma
por: Tang, Xao X., et al.
Publicado: (2022) -
MKI UFOs at Injection
por: Baer, T, et al.
Publicado: (2011)